Commentary
Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
Arthritis Research & Therapy 2005, 7:121-123 doi:10.1186/ar1742
Accesses
- Last 30 days: 33 accesses
- Last 365 days: 351 accesses
- All time: 2271 accesses

